Hematopoietic stem cell transplantation for chronic inflammatory demyelinating polyradiculoneuropathy.

Richard K BurtRoumen BalabanovJinny TaveeXiaoqiang HanRobert SufitSenda Ajroud-DrissBorko JovanovicKathleen QuigleyIndira ArnautovicIrene HelenowskiBasil Sharrack

Published in: Journal of neurology (2020)

A randomized trial is indicated to verify these results and confirm that HSCT reverses disability and offers long-term immune therapy independence.

Keyphrases

multiple sclerosis
acute myeloid leukemia
oxidative stress
hematopoietic stem cell
stem cells
drug induced